Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Joseph M Caporusso, D.P.M.
Futuro Clinical Trials
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Center for Clinical Research
Carmichael, California, United States
- Center for Clinical Research
Castro Valley, California, United States
- Limb Preservation Platform
Fresno, California, United States
- Center for Clinical Research
San Francisco, California, United States
- Ild Research Center
Vista, California, United States
- Acclaim Bone & Joint Institute and Plastic Surgery
Fort Worth, Texas, United States
- Futuro Clinical Trials
McAllen, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jan 2021
- Primary completion
- 31 Mar 2024
- Completion
- 31 Jan 2025
- Last update posted
- 20 Mar 2024
- Registered enrollment
- 82
- Registry id
- NCT04667416
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.